As per the research conducted by Market Research Future (MRFR), Meningococcal Vaccines Market Size is projected to be worth USD 5.91 billion by 2030, registering a CAGR of 7.29% during the forecast period (2022 - 2030), The market was valued USD 3.12 billion in 2021. The growing adoption of vaccination to eliminate bacterial meningitis is expected to increase the demand for immunization therapies, which can augment the global market in the assessment period. The growing initiatives by the government and various authorities to counter the increasing prevalence of meningitis is likely to offer efficient methods of immunization, which is predicted to strengthen the industry. Furthermore, the surging funds for RD are projected to combat the increasing cases of meningococcal infection that is likely to offer lucrative opportunities to vaccine manufacturing companies, which can boost the trade.